+499.5%
MRNA vs ECL
+3.0%
+496.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ECL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.1% | -2.3% | -2.4% |
| 7D | +5.5% | -2.6% | +8.1% | +9.1% |
| 30D | +158.7% | -2.2% | +160.9% | +168.1% |
| 3M | +182.1% | +10.1% | +172.0% | +171.2% |
| 6M | +151.8% | -5.7% | +157.6% | +171.4% |
| YTD | +393.6% | +7.0% | +386.6% | +386.3% |
| 1Y | +499.5% | +2.7% | +496.8% | +513.8% |
| All | +499.5% | +3.0% | +496.4% | +513.8% |
Cumulative growth
Daily Returns
Daily percentage return beside ECL.
Daily Out/Under-Performance
Portfolio return minus ECL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ECL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ECL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling